Pushing Therapeutic Boundaries in CLL

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Improving CLL Point-of-Care Decisions Utilizing BTK Inhibitors

Recorded on Tuesday, August 24, 2021

Healthcare providers can receive CME credit for important CLL topics with speakers Drs. Matthew Davids and Susan O’Brien.

Novel targeted therapies such as BTK inhibitors are bringing hope to (chronic lymphocytic leukemia) CLL patients. Yet tailored therapies can make determining the right options complex. Join expert hematologists and oncologists to review recommended therapy selection strategies, discuss key treatment combinations and evaluate BTK inhibitors for managing relapsed or refractory disease. You can earn AMA PRA Category 1 Credit™.

Recorded Sessions

Emerging Combinations for Newly Diagnosed CLL

High‐Risk Relapsed/Refractory (R/R) CLL

Watch Here

Treatment and Research

Watch and Wait

Indications for Treatment

CAR-T and Other Cellular Therapies

Frontline Therapies

Relapsed/Refractory or Later Therapies

Richter’s Transformation

MRD and Disease Monitoring

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.

Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures

CAR-T and Other Cellular Therapies in CLL: The Present and Future

ASH 2021: Dr. Deborah Stephens on Racial Disparities in Telemedicine Uptake During the COVID-19 Pandemic Among Patients with Blood Cancers

Q&A with Dr. Josh Hill on Monkeypox

ASH 2021: Dr. Megan Thompson on Outcomes of Subsequent Therapies after Exposure to Bruton’s Tyrosine Kinase Inhibitors and Venetoclax

ASH 2021: Dr. Jeff Sharman on Zanubrutinib for BTK Inhibitor-Intolerant Patients with Chronic Lymphocytic Leukemia (CLL)

CLL SOCIETY FAST FIND

One click to our most popular content.

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF
CLL HEALTHCARE PROVIDERS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ADVOCACY

QUICK LINKS

UPCOMING
EVENTS

CLL SOCIETY
SUPPORT GROUPS

LIST OF
CLL HEALTHCARE PROVIDERS

OFFICIAL STATEMENTS AND GUIDELINES

CLL GLOSSARY

CLL SOCIETY
IN THE NEWS

ADVOCACY

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others